arrow
N

Nicolas Piriou

chunantes
H指数:31
被引数:6,616

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rivaroxaban for Stroke Prevention in Hypertrophic Cardiomyopathy Without Atrial Fibrillation and With Impaired Left Atrial Reservoir Strain: Design and Rationale of the LA-HCM Randomized Trial

利伐沙班预防无房颤的高血压性心肌病伴左房储备应变受损患者的卒中:LA-HCM随机试验的设计与原理

2026-10-080
PRE
Characteristics and Prognosis of Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Diagnosed Before 65 Years Old

野生型甲状腺素转运蛋白淀粉样变性心肌病在65岁前确诊患者的特征与预后

2025-11-010
OAAI
The Healthcare Amyloidosis European Registry (HEAR): design of a national registry with a European extension strategy, and foundation of the F-CRIN GRACE network

医疗淀粉样变性欧洲登记系统(HEAR):一项具有欧洲扩展策略的国家登记系统设计,以及F-CRIN GRACE网络的建立

2025-10-280
OAAI
Impact of Prior Exercise Practice on Disease Characteristics in Desmoplakin-Related Arrhythmogenic Left Ventricular Cardiomyopathy

先前运动训练对桥粒心蛋白相关致心律失常性左心室心肌病疾病特征的影响

2025-07-030
PRE
Diagnostic pathway for cardiac amyloidosis from the healthcare professional’s perspective: results from the French DIAM-ATTR survey

从医疗专业人员角度的心脏淀粉样变性诊断路径:法国DIAM-ATTR调查结果

2025-06-300
OAAI
Immune checkpoint inhibitor-associated myocarditis: a novel risk score

免疫检查点抑制剂相关心肌炎:一种新型风险评分

2025-06-180
PRE
Polymorphic Size of Lipoprotein(a) and Structural Bioprosthetic Valve Degeneration

脂蛋白(a)多态性大小与结构性生物假体瓣膜退化

2025-06-110
PRE
Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The Tri.Fr Randomized Clinical Trial

经导管边缘到边缘修复严重孤立性三尖瓣反流: Tri.Fr随机临床试验

2025-01-140
PRE
Calcification of surgical aortic bioprostheses and its impact on clinical outcome
2024-04-120
PRE
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
2024-01-032
OA
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (oct, 10.1038/s41591-023-02591-2, 2023)
2023-11-270
OA
Machine Learning-Based Phenogrouping in MVP Identifies Profiles Associated With Myocardial Fibrosis and Cardiovascular Events
2023-10-016
OAAI